✦ LIBER ✦

Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues

✍ Scribed by Campsen, Jeffrey; Zimmerman, Michael; Trotter, James; Hong, Johnny; Freise, Chris; Brown, Robert; Cameron, Andrew; Ghobrial, Mark; Kam, Igal; Busuttil, Ronald; Saab, Sammy; Holt, Curtis; Emond, Jean; Stiles, Jessica; Lukose, Thresiamma; Chang, Matthew; Klintmalm, Goran

Book ID: 121181565
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 500 KB
Volume: 19
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.23703

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nucleoside plus nucleotide analogs and c

Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective

✍ Wesdorp, D.J.W.; Knoester, M.; Braat, A.E.; Coenraad, M.J.; Vossen, A.C.T.M.; Cl 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 917 KB

Graft versus host disease in a liver tra

Graft versus host disease in a liver transplant patient with hepatitis B and hepatocellular carcinoma

✍ H.J Merhav; M Landau; A Gat; E Gazit; M Baratz; A Bialy-Golan; F Konikof; S Bril 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Excellent Liver Transplantation Survival

Excellent Liver Transplantation Survival and Prevention of Hepatitis B Recurrence Using Hepatitis B Immunoglobulin and Nucleoside or Nucleotide Analogue Along With Treating Physician Adherence to Treatment Protocol

✍ Lindenger, C.; Castedal, M.; Cahlin, C.; Friman, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 482 KB

Hepatitis B virus in alcoholic liver dis

Hepatitis B virus in alcoholic liver disease with hepatocellular carcinoma

✍ Christian Bréchot 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Pharmacokinetics, efficacy and safety of

Pharmacokinetics, efficacy and safety of intramuscolare and intravenous of hepatitis B immunoglobulins combined with nucleoside analogues in prophylaxis of hepatitis B after liver transplantation

✍ A. Marzano; P. Andreone; R. Volpes; D. Canova; C. Cursaro; A. Riili; B. Fiorenti 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Outcome of liver transplantation for hep

Outcome of liver transplantation for hepatitis B in the United States

✍ W. Ray Kim; John J. Poterucha; Walter K. Kremers; Michael B. Ishitani; E. Rollan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

Important innovations, such as hepatitis B immune globulin (HBIG) and lamivudine, have been introduced to the care of patients undergoing liver transplantation (OLT) for viral hepatitis B (HBV) (over the last 15 years). We analyzed survival of OLT recipients with HBV in the United States to examine